Publications

5600 Results

Primary Analysis of the Randomized Phase Ii Trial of Bortezomib, Lenalidomide, Dexamthasone with/without Elotuzumab for Newly Diagnosed, High Risk Multiple Myeloma (SWOG-1211)

Authors
S Usmani;S Ailawadhi;A Hoering;R Sexton;B Lipe;S Hita;J Zonder;M Dhodapkar;N Callandar;P Voorhees;B Durie;S Rajkumar;P Richardson;R Orlowski
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 8507); American Society of Clinical Oncology Annual Meeting (5/29-6/2/20, Chicago, IL), oral
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
S1211

PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (EA8143): A trial of the ECOG-ACRIN Cancer Research Group

Authors
L Harshman;A Puligandla;N Haas;M Allaf;C Drake;D McDermott;S Signoretti;D Cella;R Gupta;B Shuch;T Choueiri;P Lara;A Kapoor;D Heng;M Jewett;V Master;M Michaelson;B Leibovich;D Maskens;M Carducci
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr TPS5101); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8143

Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously treated advanced squamous lung cancer (sqNSCLC)

Authors
M Redman;V Papadimitrakopoulou;K Minichiello;D Gandara;F Hirsch;P Mack;L Schwartz;E Vokes;S Ramalingam;N Leighl;J Bradley;M LeBlanc;S Malik;V Miller;E Sigal;S Adam;CD Blanke;K Kelly;RS Herbst
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 9576); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Lung
Study Number(s)
S1400

Racial Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the NCI Compared to Pharmaceutical Companies

Authors
J Unger;D Hershman;R Osarogiagbon;A Gothwal;S Anand;NA Dasari;M Overman;J Loree;K Raghav
Journal / Conference
American Association for Cancer Research (June 22, 2020, virtual meeting), poster
Year
2020
Research Committee(s)
Cancer Care Delivery

SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma

Authors
A Algazi;M Othus;A Daud;R Lo;J Mehnert;T-G Truong;R Conry;K Kendra;G Doolittle;J Clark;M Messino;D Moore;C Lao;B Faller;R Govindarajan;A Harker-Murray;L Dreisbach;J Moon;K Grossmann;A Ribas
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA), oral
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
S1320

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Small Bowel Cancer Cohort

Authors
YK Chae;M Othus;SP Patel;M Zalupski;A Kasi;M Khalil;A Kalyan;B Polite;S Fenton;S Gurung;C McLeod;F Giles;HX Chen;E Sharon;E Mayerson;M Plets;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA), oral
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Salivary Gland Tumor Cohort

Authors
YK Chae;M Othus;SP Patel;J Ohr;F Worden;J Suga;A Naing;S Fenton;H Kang;S Gurung;C Mcleod;F Giles;HX Chen;E Sharon;E Mayerson;M Plets;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA)
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies

Authors
J Unger;D Hershman;R Osarogiagbon;A Gothwal;S Anand;NA Dasari;M Overman;J Loree;K Raghav
Journal / Conference
American Association for Cancer Research (June 22, 2020, virtual meeting), poster
Year
2020
Research Committee(s)
Cancer Care Delivery

Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial

Authors
L Hurwitz;I Kulac;B Gumuskaya;J Baena-Del Valle;I Benedetti;F Pan;JO Liu;M Marrone;K Arnold;P Goodman;C Tangen;MS Lucia;IM Thompson;CG Drake;W Isaacs;W Nelson;A De Marzo;EA Platz
Journal / Conference
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Oct;13(10):853-862; Jun 24;canprevres.0450.2019. doi: 10.1158/1940-6207.CAPR-19-0450. Online ahead of print.
Year
2020
Research Committee(s)
Cancer Control
PMID
PMID32581009
PMC
PMC7541466
Study Number(s)
SWOG-9217

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Authors
M Roschewski;K Dunleavy;JS Abramson;BL Powell;B Link;P Patel;PJ Bierman;D Jagadeesh;S Parekh;S Nagpal;TE O'Brien;R Mitsuyasu;D Peace;PR Watson;R Battini;W Hanna;C Melani;AN Lucas;SM Steinberg;S Pittaluga;ES Jaffe;JW Friedberg;BS Kahl;R Little;NL Bartlett;M Finale;A Noy;WH Wilson
Journal / Conference
Journal of Clinical Oncology Aug 1;38(22):2519-2529; May 26;JCO2000303. doi: 10.1200/JCO.20.00303. Online ahead of print
Year
2020
Research Committee(s)
Lymphoma
PMID
PMID32453640
PMC
PMC7392744
Study Number(s)
CTSU/9177